Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M910340199 on March 23, 2000

J. Biol. Chem., Vol. 275, Issue 23, 17281-17287, June 9, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/23/17281    most recent
M910340199v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasiljeva, L.
Right arrow Articles by Kääriäinen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasiljeva, L.
Right arrow Articles by Kääriäinen, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of a Novel Function of the Alphavirus Capping Apparatus

RNA 5'-TRIPHOSPHATASE ACTIVITY OF Nsp2*

Lidia Vasiljeva, Andres Merits, Petri Auvinen, and Leevi KääriäinenDagger

From the Program in Cellular Biotechnology, Institute of Biotechnology, Biocenter Viikki, University of Helsinki, FIN-00014, Helsinki, Finland

Received for publication, December 22, 1999, and in revised form, March 14, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Both genomic and subgenomic RNAs of the Alphavirus have m7G(5')ppp(5')N (cap0 structure) at their 5' end. Previously it has been shown that Alphavirus-specific nonstructural protein Nsp1 has guanine-7N-methyltransferase and guanylyltransferase activities needed in the synthesis of the cap structure. During normal cap synthesis the 5' gamma -phosphate of the nascent viral RNA chain is removed by a specific RNA 5'-triphosphatase before condensation with GMP, delivered by the guanylyltransferase. Using a novel RNA triphosphatase assay, we show here that nonstructural protein Nsp2 (799 amino acids) of Semliki Forest virus specifically cleaves the gamma ,beta -triphosphate bond at the 5' end of RNA. The same activity was demonstrated for Nsp2 of Sindbis virus, as well as for the amino-terminal fragment of Semliki Forest virus Nsp2-N (residues 1-470). The carboxyl-terminal part of Semliki Forest virus Nsp2-C (residues 471-799) had no RNA triphosphatase activity. Replacement of Lys-192 by Asn in the nucleotide-binding site completely abolished RNA triphosphatase and nucleoside triphosphatase activities of Semliki Forest virus Nsp2 and Nsp2-N. Here we provide biochemical characterization of the newly found function of Nsp2 and discuss the unique properties of the entire Alphavirus-capping apparatus.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Semliki Forest virus (SFV)1 is member of the Alphavirus genus of the Togaviridae family. SFV has a positive-stranded 42 S RNA genome of 11.5 kilobases. RNA replication of SFV takes place in the cytoplasm and is catalyzed by the viral RNA-dependent RNA polymerase, which contains the virus-specific proteins Nsp1-4. These are cleavage products of a large (2342 aa) nonstructural polyprotein P1234. In the RNA polymerase complex all Nsps are in close association with each other (1, 2). The parental 42 S RNA is copied to complementary minus-strands, which in turn are used as templates for the synthesis of new 42 S RNA plus-strands and subgenomic 26 S mRNAs. During plus-strand synthesis, the 5' ends of the 42 S and 26 S RNAs become modified with covalently attached m7GpppA (the cap0 structure) (3-5). Capping of the RNAs is believed to be obligatory also for the replication of Alphavirus, since a point mutation specifically destroying the guanylyltransferase activity of Nsp1 is lethal for the virus (6).

The functions of Alphavirus Nsps in replication have been studied using various genetic and biochemical approaches (1, 2). Nsp4 is the catalytic component of the RNA polymerase (7, 8), whereas the functions of the phosphoprotein Nsp3 (9) are poorly defined (10, 11). Nsp2 has several distinct functions. It has nucleoside triphosphatase (NTPase) activity at its amino-terminal half (12), which is vital for the virus replication (13). Nsp2 has RNA helicase activity, which utilizes NTP hydrolysis as the energy source (14). The carboxyl-terminal part of the protein is a papain-like protease responsible for the autocatalytic cleavages of the nonstructural polyprotein (2, 15, 16). The carboxyl-terminal part has a nuclear localization sequence, which is responsible for sequestering of about half of the molecules to the nucleus during infection (17, 18). Furthermore, Nsp2 regulates transcription of the subgenomic 26 S RNA (Ref. 19 and references therein). Here we show that Nsp2 has yet an additional activity required for capping of the virus mRNAs.

Capping of cellular mRNAs occurs in the nucleus and comprises four different reactions. RNA 5'-triphosphatase removes the gamma -phosphate from the 5' end of the nascent RNA molecule (pppRNA right-arrow ppRNA). Guanylyltransferase reacts with a GTP molecule to form a covalent complex with GMP, which is then transferred from guanylyltransferase to the 5' end of RNA to form G(5')ppp(5')NpRNA. Methylation by guanine-7N-methyltransferase yields an RNA molecule with the cap0 structure (m7GpppNpRNA). Further methylation by nucleoside-2'-O-methyltransferase of the riboses of the penultimate and the adjacent nucleotides yields cap1 and cap2 structures, respectively (20, 21).

Unlike cellular mRNAs, the capping of Alphavirus RNAs takes place in the cytoplasm and is carried out by reactions that differ from the nuclear reactions as follows. (i) Nsp1 catalyzes transfer of the methyl group from S-adenosylmethionine to GTP to yield m7GTP (methyltransferase reaction), and (ii) a covalent guanylate complex Nsp1-m7GMP is formed (22-25). Here, we show that Nsp2 of SFV and Sindbis virus possess RNA triphosphatase activity, which is localized to the amino-terminal half of the protein. Comparison with other capping enzymes suggests that the Alphavirus-capping apparatus is a unique complex.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Expression and Purification-- Semliki Forest virus nonstructural proteins Nsp1, Nsp2, Nsp3, Nsp4, the Nsp2 (K192N) mutant, the amino-terminal part of Nsp2 (aa 1-470) (Nsp2-N), the carboxyl-terminal part of Nsp2 (aa 470-799), and Sindbis virus Nsp2 were expressed in Escherichia coli BL21(DE3) (Stratagene) using pHAT plasmids encoding amino-terminal His6 tags (26). The proteins were purified using Ni2+ affinity chromatography as described (12). Protein concentration was determined using the Bradford assay (27) and Bio-Rad reagents. The purity of proteins was verified by SDS-PAGE in 10% gels.

RNA Synthesis-- Two different plasmids were used to produce RNA substrates: pGEM3Zf(+) purchased from Promega, and pUC18Omega . Omega (Omega ) leader (1-68 nucleotides) of tobacco mosaic virus was first amplified from infectious cDNA clone tobacco mosaic virus 304 (a kind gift by Dr. Kirsi Lehto, University of Turku) using cloned Pfu polymerase (Stratagene) and oligonucleotides 5'-CTGAATTCATTTAGGTGACACTATAGAATTTTTACAACAATTACCA-3' and 5'-GGTAGCTGTCTGTGTCTAGAATATTGTAATTGTAAATAGT-3' as upstream and downstream primers, respectively. The upstream primer was designed to contain the SP6 promoter sequence (underlined), and the downstream primer included the SspI site (underlined). The polymerase chain reaction fragment digested with EcoRI and XbaI was then gel-purified and ligated with the EcoRI/XbaI cut vector pUC18 (New England Biolabs). RNAs were prepared by in vitro transcription of pGEM3Zf(+) cut with EcoRI (RNA1) or pUC18Omega cut with SspI (RNA2). Synthesis of RNA probes was carried out in 50 µl of Promega transcription buffer in the presence of 0.5 mM each NTP (Amersham Pharmacia Biotech), 50 µCi of either [gamma -32P] or [alpha -32P]GTP (Amersham Pharmacia Biotech; 5000 Ci/mmol), 40 units of RNasin (Promega), 40 units of SP6 RNA polymerase (Promega), and 2.5 to 5 µg of a linear DNA substrate. After incubation at 37 °C for 1 h, the transcription products were extracted with phenol/chloroform (1:1) and purified by PAGE in 10% gels containing 7 M urea. Radioactive bands were excised, and the RNA was eluted from the gel with a buffer containing 20 mM Tris-HCl, pH 8.0, 300 mM ammonium acetate, and 1 mM EDTA for 3 h at room temperature and precipitated with ethanol. To produce RNAs with lower specific radioactivity, transcription was carried out in 50 µl of 120 mM HEPES-KOH, pH 7.5, buffer containing 24 mM MgCl2, 1 mM spermidine, 20 mM dithiothreitol, 5 mM each NTP, 50 µCi of either [gamma -32P]GTP or [alpha -32P]GTP, 40 units of RNasin, 80 units of SP6 RNA polymerase, and 5 to 10 µg of a DNA substrate ( 28). The mixtures were incubated at 37 °C for 2 h, and the reaction was stopped by the addition of 1 unit of DNase RQ (Promega) per 1 µg of input DNA template. Incubation was continued for a further 15 min at 37 °C. The resultant RNA samples were extracted with phenol/chloroform (1:1) and chloroform, precipitated with 3 M LiCl, and dissolved in sterile water, followed by additional purification of the RNA preparations in Sephadex G25 spin columns (Amersham Pharmacia Biotech). RNA concentrations were measured by absorbance at 260 nm. The purity of the RNAs was controlled PAGE in 10% gel containing 7 M urea.

RNA Triphosphatase Assay-- Two different methods were used to assay RNA 5'-triphosphatase activity. The first assay was based on the liberation of the gamma -phosphate group from the gamma  -32P-labeled RNA substrates. In this case, the RNA triphosphatase reaction mixture (40 µl) contained 20 mM Tris-HCl, pH 8.0, 1 mM MgCl2, 5 mM KCl, 150 mM NaCl, 2 mM dithiothreitol, and 0.2-5 µmol of a [gamma -32P]RNA substrate and 0.1-1 pmol of the enzyme. Reactions were carried out for 20 min at 25 °C. The reaction products were separated by PAGE as above. The radioactive bands were visualized by autoradiography. Alternatively, the release of radioactive phosphate was measured by phosphoimaging (BAS-1500; Fuji) as the decrease of the radioactivity of the [gamma -32P]RNA band. Identical untreated electrophoresed samples served as controls in each assay.

In the second assay, the terminal GTP at the 5' end of the substrate RNA was selectively labeled at the alpha -phosphate position during transcription. The RNA triphosphatase reaction was carried out as above and stopped by phenol/chloroform extraction. The RNA was precipitated with ethanol and dissolved in TE buffer (10 mM Tris HCl, pH 8.0, and 1 mM EDTA). The RNA (100 µg/ml) was treated with RNase T1 (100 units/ml) (Roche Molecular Biochemicals) at 30 °C to release the 5'-terminal guanylate. Aliquots from the Rnase-treated samples were spotted onto polyethyleneimine (PEI)- cellulose thin layer chromatography (TLC) plates (Merck) and developed with 1 M LiCl. Spots of labeled nucleotides were visualized using autoradiography or phosphoimaging analysis.

GTPase Assay-- Reaction mixtures (10 µl) containing 20 mM Tris-HCl, pH 7.5, 2 mM MgCl2, 5 mM KCl, 150 mM NaCl, 2 mM dithiothreitol, 50-200 µM GTP, 0.2 µCi of [gamma -32P]GTP (Amersham Pharmacia Biotech; 5000 Ci/mM), and 0.1-1 pmol of enzyme were incubated at 37 °C for 30-60 min. Aliquots from reaction mixtures were spotted onto PEI-cellulose TLC plates and developed with 1 M formic acid, 1 M LiCl. Spots of GTP and the newly formed inorganic phosphate (Pi) were visualized by autoradiography. Radioactivity in the Pi spots was also measured by phosphoimaging.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Nsp2 Is an RNA Triphosphatase-- To test possible RNA triphosphatase activity of the SFV nonstructural proteins, Nsp1, Nsp2, Nsp3 and Nsp4 were expressed in E. coli and purified using metal-chelating chromatography as described before (12). Assay mixtures containing serial dilutions of the different Nsps were incubated for 30 min at 25 °C in the presence of a 64-nucleotide-long RNA substrate (RNA1). The 5'-terminal G of the RNA was labeled with [gamma -32P]GTP during the transcription. Reaction products were separated by PAGE under denaturing conditions, and the RNA triphosphatase activity was measured as a decrease in the intensity of the labeled RNA band (Fig. 1). Among the four Nsps tested, only Nsp2 was able to remove the label from the substrate RNA1 (Fig. 1, Nsp2). The assay was also performed with the Nsp2 protein containing a single amino acid change (K192N) in the nucleotide-binding site (Fig. 2). This mutation has been shown to destroy the NTPase activity of Nsp2 (12). The mutant protein (K192N) had no detectable triphosphatase activity when used within the same concentration range as the wild type Nsp2 (Fig. 1, K192N).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Identification of 5'-RNA triphosphatase activity of the Alphavirus Nsps. 5'-[gamma -32P]GTP-RNA1 was synthesized by in vitro transcription using SP6 polymerase. RNA1 (1 µM) was incubated under standard RNA triphosphatase reaction conditions with SFV Nsp1, Nsp2, Nsp3, Nsp4, Nsp2 mutant (K192N), Nsp2-N, Nsp2-C, and SIN Nsp2. Concentrations of purified Nsp in the reaction mixtures: lanes 1, no protein added; lanes 2, 8 fmol; lanes 3, 40 fmol; lanes 4, 400 fmol. PAGE was performed in 10% gel in the presence of 7 M urea.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Amino acid sequence of amino-terminal part of SFV Nsp2 (1 to 470 aa) harboring the RNA triphosphatase and NTPase activities. Residues representing the conserved NTP binding motif (1) present in Alphavirus Nsp2 s are underlined. The critical lysine (Lys-192) residue needed for NTPase (12) and RNA helicase (14) as well as for RNA triphosphatase activity (in this study) is shown in boldface.

To find out which part of the multifunctional Nsp2 harbors the RNA triphosphatase activity, we expressed and purified two halves of the Nsp2 molecule separately. The amino-terminal half Nsp2-N (residues 1-470) had similar RNA triphosphatase activity as the complete Nsp2 (Fig. 1, Nsp2-N), whereas the carboxyl-terminal half Nsp2-C (470-799 aa) had no activity (Fig. 1, Nsp2-C). As expected, the K192N mutation in the Nsp2-N fragment rendered it inactive (not shown). Finally, it was interesting to know whether Nsp2 of another Alphavirus also possessed RNA triphosphatase activity. To this end, we expressed in E. coli and purified Sindbis virus Nsp2 (Nsp2SIN) following the same protocol as for the SFV Nsp2. Also, SIN Nsp2 could remove the gamma -labeled phosphate from RNA1 and from [gamma -32P]GTP (see Fig. 3).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 3.   Hydrolysis of GTP by SIN Nsp2. Shown is the PEI-TLC analysis of products of the GTPase reaction catalyzed by SIN Nsp2. The reaction was carried out in the presence of 0.1 pmol of SIN Nsp2. Time of incubation: lane 1, 0 min; lane 2, 1 min; lane 3, 2 min; lane 4, 3 min; lane 5, 5 min; lane 6, 10 min; lane 7, 20 min. GTPase activity was detected as the release of [gamma -32P]phosphate (Pi) from [gamma -32P]GTP. The positions of Pi and GTP are indicated. RNA was analyzed as in Fig. 1.

Nsp2 Hydrolyzes only the gamma ,beta -Triphosphate Bond at the 5' End of RNA-- Control experiments were devised to exclude the possibility that the Nsp2 preparation contained nonspecific phosphatase or nuclease activities. In these experiments, we used a 70-nucleotide-long RNA molecule representing tobacco mosaic virus Omega  leader RNA (RNA2), which has only a single guanylate residue at the 5' end. During transcription, the 5' end of RNA2 was labeled either with [alpha -32P]GTP or [gamma -32P]GTP (Figs. 4). These RNAs were treated with different amounts of Nsp2, and the products were analyzed by PAGE. No decrease in the radioactivity was observed for RNA preparations labeled at the alpha -position (Fig. 4A), whereas reduction of radioactivity was clearly seen in Nsp2-treated RNA preparations labeled at the gamma -position (Fig. 4B). Thus, we conclude that the Nsp2 preparation did not contain any nonspecific nuclease activity, and that Nsp2 released gamma -phosphate but not alpha -phosphate from the 5' end of RNA2.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 4.   Nsp2 releases 5' gamma -phosphate from an RNA substrate. The substrate RNA was synthesized by SP6 transcription in vitro. The reactions were performed under standard conditions using 1 µmol of 5'-[alpha -32P]GTP-terminated RNA2 (A) and 5'-[gamma 32-P]GTP-terminated RNA2 (B) followed by treatment with SFV Nsp2. Concentration of SFV Nsp2 in the reaction mixtures: lanes 1, no protein added; lanes 2, 8 fmol; lanes 3, 400 fmol.

The following experiment was carried out to ensure that Nsp2 cleaves only gamma -phosphate but not beta -phosphate group. RNA2 labeled at the alpha -position was first exposed to Nsp2. A similar untreated RNA2 preparation served as a control. Both RNA samples were thereafter digested with ribonuclease T1, which can cleave from RNA2 only the 5'-terminal guanylate residue. The digestion mixtures were analyzed by thin layer chromatography on PEI plates using unlabeled GMP, GDP, and GTP as markers. The untreated control RNA2 preparation yielded only radioactive GTP, whereas RNA2 that had been exposed to Nsp2 yielded radioactive GDP (Fig. 5). Thus, we conclude that Nsp2 is a genuine RNA triphosphatase that cleaves only the bond between gamma  and beta  phosphates at the 5' end of the substrate RNA molecule.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Specificity of Nsp2 RNA triphosphatase. [alpha -32P]GTP-labeled RNA2 (with a single G at its 5' end) was treated with 0.1 pmol of Nsp2 or untreated. The preparations were digested with RNase T1, and the released guanylate was analyzed by thin layer chromatography on PEI plates. Time of treatment: lanes 1 and 4, 0 min; lanes 2 and 5, 15 min; lanes 3 and 6, 30 min. The positions of the origin (ORI) and the nucleotide markers are indicated with arrows. The labeled alpha -phosphate of the 5'-terminal guanylate is in boldface.

Enzymatic Properties of Nsp2 Triphosphatase of SFV-- The RNA triphosphatase activity was optimized for Nsp2-N fragment with respect to divalent cation concentration. For comparison, the optimization was also carried out for the NTPase activity of Nsp2-N using gamma -labeled GTP as the substrate. The optimal MgCl2 concentration for the GTPase reaction was 5 mM, and only a slight decrease of activity was observed with higher concentrations (Fig. 6A, open circles). Interestingly, there was a sharp maximum at 0.1 mM for MnCl2 (Fig. 6A, closed symbols). For RNA triphosphatase, the optimal Mg2+ concentration was 1.0-2.0 mM, whereas a sharp maximum of activity was obtained with a Mn2+ concentration of 0.1 mM (Fig. 6B). Our results concerning NaCl dependence indicate that monovalent cations stimulate the RNA triphosphatase activity but within a wide concentration range (Fig. 7A). The RNA triphosphatase activity had a wide pH range with an optimum at pH 7-8 (Fig. 7B). To test the effect of temperature, the rates of hydrolysis of [gamma -32P]triphosphate-terminated RNA were determined at 20 °C, 25 °C, 37 °C, and 42 °C. The maximum rate of hydrolysis was achieved at 25 °C, whereas incubation at 42 °C apparently resulted in inactivation of the enzyme (Fig. 7C).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   Divalent cation specificity of SFV GTPase and RNA triphosphatase. GTPase activity (A) was measured at 0.1 µM GTP, and RNA triphosphatase activity (B) was measured at 1 µM concentration of the 5'-[gamma -32P]RNA2 substrate. Reactions were performed in the presence of 0.1 pmol of Nsp2 and varying concentrations of MnCl2 () or MgCl2 (open circle ). The arrowheads indicate the values obtained in the presence of 1 mM EDTA.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of monovalent cations (A), pH (B), and temperature (C) on RNA triphosphatase activity. The RNA triphosphatase assays were performed using 5'-[gamma -32P]RNA2 as substrate and 0.1 pmol of Nsp2.

Knowing the optimal conditions for the RNA triphosphatase and NTPase, the apparent Km values were estimated for both reactions. The reaction initial velocity, measured within the first 20 min of incubation, was plotted as a function of the substrate concentration according to the equations by Lineweaver and Burk (Fig. 8). The RNA triphosphatase reaction catalyzed by Nsp2-N reached its maximum at 0.055 µM/min, and the apparent Km was 2.99 µM (Fig. 8A). Kcat of 5.5 min-1, determined for the RNA triphosphatase reaction, indicated that the gamma -phosphate from 5.5 molecules of RNA was hydrolyzed/min. A much lower apparent substrate affinity (Km value of 90 µM) was obtained for the NTPase activity of Nsp2 (Fig. 8B). The maximal velocity (2.3 µM/min) and the kinetic constant Kcat (230 min-1) for the Nsp2-N-catalyzed NTPase reaction were also calculated from the double-reciprocal Lineweaver-Burk plot. These data indicate that Nsp2-N of SFV had about a 30-fold higher affinity for RNA than for the nucleoside triphosphate.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 8.   Kinetic analysis of RNA triphosphatase and NTPase activities of SFV Nsp2. Shown is a Lineweaver-Burk plot for the RNA triphosphatase (A) and NTPase (B) reaction catalyzed by SFV Nsp2-N. Reaction mixtures contained 0.1 pmol of Nsp2, and reactions at variable concentrations of substrate RNA and GTP were performed for 20-min periods. Each data point represents the average of duplicate reactions. The arrows indicate the position of (-1/Km) on the 1/S axis and (-1/Vmax) on 1/v axis.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The role of the nonstructural protein Nsp1 in the capping of the viral RNAs has been well established. First, it was shown that Nsp1 has guanine-7N-methyltransferase activity (29). However, the properties of this enzyme were different from those of previously known capping enzymes. Nsp1 could not methylate an unmethylated cap at the 5' end of RNA. Instead, it catalyzed the methylation GTP, dGTP, and GpppG, but not of GpppA, which is the 5' dinucleotide of Alphavirus 42 S and 26 S RNAs (22, 30). This led us to discover a novel guanylyltransferase activity of Nsp1, which unlike other capping enzymes, forms a covalent complex with m7GMP instead of GMP (23, 24). As neither of these reactions takes place in uninfected host cells, they are potential targets for development of antiviral drugs (30).

Since removal of gamma -phosphate from the nascent 5' end of RNA is an essential step in the capping of mRNAs, we started to look for RNA triphosphatase activity among the virus-specific components of the RNA polymerase. Here we show that of the four nonstructural proteins of SFV, only Nsp2 had RNA triphosphatase activity, which was confined to the amino-terminal half of the protein together with the previously discovered nucleoside triphosphatase activity (12, 13). To ensure that the RNA triphosphatase and NTPase activities are properties of the Alphavirus family, we produced and also assayed Nsp2 of Sindbis virus. Both activities, indistinguishable from those of SFV Nsp2, were associated with the Nsp2 of Sindbis virus (Fig. 1, Nsp2SIN, and Fig. 2). Taking into consideration the significant amino acid sequence homology among Alphavirus Nsps, one could suggest that Nsp2 proteins of all Alphavirus have both RNA triphosphatase and NTPase activities.

All viral RNA triphosphatases discovered so far have been shown to have also NTPase activity (Table I). The Km values of the RNA triphosphatase and NTPase activities of vaccinia virus D1 capping protein differ considerably (1 µM and 800 µM, respectively). Competition between RNA and ATP substrates revealed that ATP inhibited the RNA triphosphatase reaction, indicating that the hydrolysis of the gamma -phosphate of both RNA and ATP takes place in the same reaction center (31). Similar results have been reported for the RNA triphosphatase/NTPase of Reovirus lambda 1 protein (32). Our preliminary competition experiments with SFV Nsp2-N with GTP and RNA substrates showed that the RNA triphosphatase activity was increased rather than decreased in the presence of GTP, strongly suggesting that the NTPase and RNA triphosphatase activities have different reaction centers (data not shown). Mutation in the NTP-binding site (K192N) abolished both activities, suggesting a close connection between them. Different reaction centers for NTPase and RNA triphosphatase have been suggested also for the Flavivirus West Nile NS3 protein (68 kDa) (38), which also has RNA helicase activity like Alphavirus Nsp2 (37, 39). Different reaction centers may be necessary for NS3 and Nsp2, since RNA helicases utilize the energy released from the hydrolysis of NTPs (14, 40). In contrast to the RNA triphosphatase activity, which is needed only in the modification of the 5' end of the nascent RNA, RNA helicase activity is required throughout the RNA replication cycle. This may mean that different Nsp2 (and possibly NS3) molecules are involved in these two processes. One part of Nsp2 molecules would be tightly associated with Nsp1 in the capping enzyme complex, and the other part could operate alone, perhaps as a homo-oligomer (40), in the RNA helicase function. This scenario might gain support from the observation that these two enzymatic activities of Nsp2 differ in respect to the optimal NaCl concentration. RNA triphosphatase is active in a wide concentration range (50 to 300 mM), whereas higher than 100 mM concentrations of NaCl were inhibitory for the RNA helicase function (14).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Properties of RNA triphosphatases
ND, not determined; NTPase, nucleoside triphosphatase; 5'-TP, RNA 5' triphosphatase; GT, guanylyltransferase.

Triphosphatases have been classified as metal-dependent and metal-independent enzymes according to the influence of divalent cations (41). The RNA triphosphatases from mammals, brine shrimp, and West Nile virus are active in the absence of divalent cations, and addition of them in fact inhibits triphosphatase activity (33, 42, 43). Interestingly, a mammalian RNA triphosphatase has been shown to have a mechanism for phosphoryl group removal similar to that of protein-tyrosine phosphatases. This class of enzymes does not require metal ions (Ref. 44 and references therein). Activities of yeast (41), Reovirus (32), vaccinia virus (21, 45), and baculovirus LEF-4 (35, 36) RNA triphosphatases are dependent on divalent cations (Table I). In this respect, Alphavirus RNA triphosphatase is similar to the other metal-dependent enzymes. However, no significant homology could be found for the amino-terminal part of Nsp2 with viral or cellular RNA triphosphatases.

Four functions of Alphavirus Nsp2, RNA triphosphatase, NTPase, RNA helicase, and protease activities, are the same as those of Flavivirus NS3. However, there is essentially no homology between NS3 and Nsp2 at the level of amino acid sequences (47). Moreover, Nsp2 is dependent on divalent cations, whereas NS3 is stimulated by EDTA. In addition, the RNA triphosphatase activity of Nsp2 is located at the amino terminus, whereas in NS3 it is in the carboxyl-terminal region of the molecule (37). Thus, our results imply that the Alphavirus RNA triphosphatase is unique among the RNA triphosphatases and exemplifies a novel divalent cation-dependent RNA triphosphatase, which is activated by both Mn2+ and Mg2+ ions.

Recently the three-dimensional structure of the divalent cation dependent RNA triphosphatase Cet1 of Saccharomyces cerevisiae has been solved at high resolution. It reveals a tunnel structure consisting of an eight-stranded antiparallel beta -barrel into which the 5' end of the RNA protrudes. The authors (48) propose a mechanism for the specific hydrolysis of the gamma -phosphate as well as for the binding of Cet1 with the guanylyltransferase subunit (Ceg1). Essential glutamate residues, conserved in baculovirus LEF 4 and vaccinia virus D1 RNA triphosphatases, are involved in the metal binding of Cet1, suggesting structural similarity between these enzymes. Secondary structure prediction for the amino-terminal part (1-360 aa) of Nsp2 suggests that it consists mostly of beta -strands similarly to Cet1. This region has also clusters of glutamate residues that could have analogous functions to Glu-305, Glu-307, Glu-492, Glu-494, and Glu-496 of Cet 1 (48-50).

The composition of the capping apparatus differs between different species. The tight association of RNA triphosphatase and guanylyltransferase activities in the same protein seems to be a characteristic feature for most eukaryotic and viral mRNA capping systems. The best characterized vaccinia virus capping enzyme is a complex of two subunits D1 (95 kDa) and D12 (33 kDa). The RNA triphosphatase and guanylyltransferase reactions are carried out by the amino-terminal part of D1, whereas the carboxyl-terminal part together with D12 is responsible for the methyltransferase activity (21). The S. cerevisiae capping apparatus consists of three proteins with RNA triphosphatase (Cet1, 80 kDa), guanylyltransferase (Ceg1, 52 kDa), and methyltransferase (Abd1, 50 kDa) activities (33, 34, 51). Metazoan species possess a two-component capping apparatus consisting of a bifunctional RNA triphosphatase/guanylyltransferase polypeptide (Hce1, 66 kDa) and a separate methyltransferase polypeptide (Hcm1, 52 kDa). The RNA triphosphatase activity is not accompanied by NTPase activity, unlike other known enzymes (41, 52). In the capping reactions catalyzed by such enzyme complexes, the order of reactions is RNA triphosphatase, then guanylyltransferase, and finally methyltransferase, which methylates the unmethylated cap at the 5' end of the nascent RNA molecule. According to these results, the Alphavirus capping apparatus consists of two replicase proteins, Nsp2, having the RNA triphosphatase activity, and Nsp1, with combined methyltransferase and guanylyltransferase activities. The guanylyltransferase and methyltransferase reactions take place in reverse order, as compared with capping of cellular and most other viral mRNAs.

The Alphavirus capping apparatus is part of an RNA replicase complex in the cytoplasm of Alphavirus-infected cells. The complex is tightly bound to the surface of modified endosomes and lysosomes (53-55) due to interaction of Nsp1 with membrane lipids. This interaction is mediated by an amphipathic peptide in the middle of the Nsp1 molecule (46) and strengthened by palmitate chains linked to the carboxyl-terminal cysteine residues 418-420 (25). Attachment of the RNA polymerase complex to the membranes implies that during the polymerization of the nascent RNA molecule the template RNA must move through the fixed polymerase complex. One of the first events during this process is the capping of the nascent RNA molecule.

    ACKNOWLEDGEMENTS

We thank Airi Sinkko and Tarja Välimäki for technical assistance and Dr. Marja Makarow and Dr. Mart Saarma for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by Academy of Finland Grant 8397, Technology Development Center (TEKES), and Center for International Mobility.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger A Biocentrum Helsinki Fellow. To whom correspondence should be addressed: Program in Cellular Biotechnology, Institute of Biotechnology, Biocenter Viikki, P. O. Box 56, University of Helsinki, FIN-00014, Helsinki Finland. Tel.: 358-9-191-59400; Fax: 358-9-191-59560; E-mail: leevi.kaariainen@helsinki.fi.

Published, JBC Papers in Press, March 23, 2000, DOI 10.1074/jbc.M910340199

    ABBREVIATIONS

The abbreviations used are: SFV, Semliki Forest virus; aa, amino acids; NTPase, nucleoside triphosphatase; PAGE, polyacrylamide gel electrophoresis; PEI, polyethyleneimine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Kääriäinen, L., Takkinen, K., Keränen, S., and Söderlund, H. (1987) J. Cell Sci. (Supp.) 7, 231-250
2. Strauss, J. H., and Strauss, E. G. (1994) Microbiol. Rev. 58, 491-562
3. Cross, R. K., and Gomatos, P. J. (1981) Virology 114, 542-554
4. Dubin, D. T., Stollar, V., Hsuchen, C.-C., Timko, K., and Guild, G. M. (1977) Virology 77, 457-470
5. Pettersson, R. F., Söderlund, H., and Kääriäinen, L. (1980) Eur. J. Biochem. 105, 435-443
6. Wang, H.-L., O'Rear, J., and Stollar, V. (1996) Virology 217, 527-531
7. Keränen, S., and Kääriäinen, L. (1979) J. Virol. 32, 19-29
8. Barton, D. J., Sawicki, S. G., and Sawicki, D. L. (1988) J. Virol. 62, 3597-3602
9. Peränen, J., Takkinen, K., Kalkkinen, N., and Kääriäinen, L. (1988) J. Gen. Virol. 69, 2165-2178
10. LaStarza, M. W., Lemm, J. A., and Rice, C. M. (1994) J. Virol. 68, 5781-5791
11. Wang, Y.-F., Sawicki, S. G., and Sawicki, D. L. (1994) J. Virol. 68, 6466-6475
12. Rikkonen, M., Peränen, J., and Kääriäinen, L. (1994) J. Virol. 68, 5804-5810
13. Rikkonen, M. (1996) Virology 218, 352-361
14. Gomez de Cedron, M., Ehsani, N., Mikkola, M., Garcia, J. A., and Kääriäinen, L. (1999) FEBS Lett. 448, 19-22
15. Hardy, W. R., and Strauss, J. H. (1989) J. Virol. 63, 4653-4664
16. Takkinen, K., Peränen, J., and Kääriäinen, L. (1991) J. Gen. Virol. 72, 1627-1633
17. Peränen, J., Rikkonen, M., Liljeström, P., and Kääriäinen, L. (1990) J. Virol. 64, 1888-1896
18. Rikkonen, M., Peränen, J., and Kääriäinen, L. (1992) Virology 189, 462-473
19. Suopanki, J., Sawicki, D. L., Sawicki, S. G., and Kääriäinen, L. (1998) J. Gen. Virol. 79, 309-319
20. Mizumoto, K., and Kaziro, Y. (1987) Prog. Nucleic Acid Res. Mol. Biol. 34, 1-28
21. Shuman, S. (1995) Prog. Nucleic Acid Res. Mol. Biol. 50, 101-129
22. Laakkonen, P., Hyvönen, M., Peränen, J., and Kääriäinen, L. (1994) J. Virol. 68, 7418-7425
23. Ahola, T., and Kääriäinen, L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 507-511
24. Ahola, T., Laakkonen, P., Vihinen, H., and Kääriäinen, L. (1997) J. Virol. 71, 392-397
25. Laakkonen, P., Ahola, T., and Kääriäinen, L. (1996) J. Biol. Chem. 271, 28567-28571
26. Peränen, J., Rikkonen, M., Hyvönen, M., and Kääriäinen, L. (1996) Anal. Biochem. 236, 371-373
27. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254
28. Gurevich, V. V., Pokrovskaya, I. D., Obukhova, T. A, and Zozulya, S. A. (1991) Anal. Biochem. 195, 207-213
29. Mi, S., and Stollar, V. (1991) Virology 184, 423-427
30. Lampio, A., Ahola, T., Darzynkiewicz, E., Stepinski, J., Jankowska-Anyszka, M., and Kääriäinen, L. (1999) Antiviral Res. 42, 35-46
31. Myette, J. R., and Niles, E. G. (1996) J. Biol. Chem. 271, 11945-11952
32. Bisaillon, M., and Lemay, G. (1997) J. Biol. Chem. 272, 29954-29957
33. Itoh, N., Mizumoto, K., and Kaziro, Y. (1984) J. Biol. Chem. 259, 13930-13936
34. Itoh, N., Yamada, H., Kaziro, Y., and Mizumoto, K. (1987) J. Biol. Chem. 262, 1989-1995
35. Gross, C. H., and Shuman, S. (1998) J. Virol. 72, 10020-10028
36. Jin, J., Dong, W., and Guarino, L. A. (1998) J. Virol. 72, 10003-10010
37. Wengler, G., and Wengler, G. (1991) Virology 184, 707-715
38. Wengler, G., and Wengler, G. (1993) Virology 197, 265-273
39. Gallinari, P., Brennan, D., Nardi, C., Brunetti, M., Tomei, L., Steinkuhler, C., and de Francesco, R. (1998) J. Virol. 72, 6758-6769
40. Bird, L. E., Subramanya, H. S., and Wigley, D. B. (1998) Curr. Opin. Struct. Biol. 8, 14-18
41. Ho, C. K., Pei, Y., and Shuman, S. (1998) J. Biol. Chem. 273, 34151-34156
42. Yagi, Y., Mizumoto, K., and Kaziro, Y. (1983) EMBO J. 2, 611-615
43. Yagi, Y., Mizumoto, K., and Kaziro, Y. (1984) J. Biol. Chem. 259, 4695-4698
44. Wen, Y., Yue, Z., and Shatkin, A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12226-12231
45. Shuman, S., and Moss, B. (1990) Methods Enzymol. 181, 170-180
46. Ahola, T., Lampio, A., Auvinen, P., and Kääriäinen, L. (1999) EMBO J. 18, 3164-3172
47. Koonin, E. V., and Dolja, V. V. (1993) Crit. Rev. Biochem. Mol. Biol. 28, 375-430
48. Lima, C. D., Wang, L. K., and Shuman, S. (1999) Cell 99, 533-543
49. Lehman, K., Schwer, B., Ho, C. K., Rouzankina, I., and Shuman, S. (1999) J. Biol. Chem. 274, 22668-22678
50. Pei, Y., Ho, C. K., Schwer, B., and Shuman, S. (1999) J. Biol. Chem. 274, 28865-28874
51. Shibagaki, Y., Itoh, N., Yamada, H., Nagata, S., and Mizumoto, K. (1992) J. Biol. Chem. 267, 9521-9528
52. Saha, N., Schwer, B., and Shuman, S. (1999) J. Biol. Chem. 274, 16553-16562
53. Froshauer, S., Kartenbeck, J., and Helenius, A. (1988) J. Cell Biol. 107, 2075-2086
54. Peränen, J., and Kääriäinen, L. (1991) J. Virol. 65, 1623-1627
55. Peränen, J., Laakkonen, P., Hyvönen, M., and Kääriäinen, L. (1995) Virology 208, 610-620


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
M. Gopinath and M. S. Shaila
RNA triphosphatase and guanylyl transferase activities are associated with the RNA polymerase protein L of rinderpest virus
J. Gen. Virol., July 1, 2009; 90(7): 1748 - 1756.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Lulla, D. L. Sawicki, S. G. Sawicki, A. Lulla, A. Merits, and T. Ahola
Molecular Defects Caused by Temperature-Sensitive Mutations in Semliki Forest Virus nsP1
J. Virol., September 15, 2008; 82(18): 9236 - 9244.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Mayuri, T. W. Geders, J. L. Smith, and R. J. Kuhn
Role for Conserved Residues of Sindbis Virus Nonstructural Protein 2 Methyltransferase-Like Domain in Regulation of Minus-Strand Synthesis and Development of Cytopathic Infection
J. Virol., August 1, 2008; 82(15): 7284 - 7297.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. Tamm, A. Merits, and I. Sarand
Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus
J. Gen. Virol., March 1, 2008; 89(3): 676 - 686.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. F. Souliere, J.-P. Perreault, and M. Bisaillon
Magnesium-binding studies reveal fundamental differences between closely related RNA triphosphatases
Nucleic Acids Res., February 2, 2008; 36(2): 451 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Montgomery and R. E. Johnston
Nuclear Import and Export of Venezuelan Equine Encephalitis Virus Nonstructural Protein 2
J. Virol., October 1, 2007; 81(19): 10268 - 10279.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
Y. P. Su, J. H. Shien, H. J. Liu, H. S. Yin, and L. H. Lee
Avian reovirus core protein {micro}A expressed in Escherichia coli possesses both NTPase and RTPase activities
J. Gen. Virol., June 1, 2007; 88(6): 1797 - 1805.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Atasheva, R. Gorchakov, R. English, I. Frolov, and E. Frolova
Development of Sindbis Viruses Encoding nsP2/GFP Chimeric Proteins and Their Application for Studying nsP2 Functioning
J. Virol., May 15, 2007; 81(10): 5046 - 5057.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Balistreri, J. Caldentey, L. Kaariainen, and T. Ahola
Enzymatic Defects of the nsP2 Proteins of Semliki Forest Virus Temperature-Sensitive Mutants
J. Virol., March 15, 2007; 81(6): 2849 - 2860.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Lulla, V. Lulla, K. Tints, T. Ahola, and A. Merits
Molecular determinants of substrate specificity for semliki forest virus nonstructural protease.
J. Virol., June 1, 2006; 80(11): 5413 - 5422.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Garmashova, R. Gorchakov, E. Frolova, and I. Frolov
Sindbis Virus Nonstructural Protein nsP2 Is Cytotoxic and Inhibits Cellular Transcription.
J. Virol., June 1, 2006; 80(12): 5686 - 5696.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. E. Galbraith, B. J. Sheahan, and G. J. Atkins
Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.
J. Gen. Virol., April 1, 2006; 87(Pt 4): 937 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Lulla, A. Merits, P. Sarin, L. Kaariainen, S. Keranen, and T. Ahola
Identification of Mutations Causing Temperature-Sensitive Defects in Semliki Forest Virus RNA Synthesis
J. Virol., March 15, 2006; 80(6): 3108 - 3111.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. L. Sawicki, S. Perri, J. M. Polo, and S. G. Sawicki
Role for nsP2 Proteins in the Cessation of Alphavirus Minus-Strand Synthesis by Host Cells
J. Virol., January 1, 2006; 80(1): 360 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Wang, W.-M. Lee, T. Watanabe, M. Schwartz, M. Janda, and P. Ahlquist
Brome Mosaic Virus 1a Nucleoside Triphosphatase/Helicase Domain Plays Crucial Roles in Recruiting RNA Replication Templates
J. Virol., November 1, 2005; 79(21): 13747 - 13758.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M.-L. Li, Y.-H. Lin, H. A. Simmonds, and V. Stollar
A Mutant of Sindbis Virus Which Is Able To Replicate in Cells with Reduced CTP Makes a Replicase/Transcriptase with a Decreased Km for CTP
J. Virol., September 15, 2004; 78(18): 9645 - 9651.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. A. Ivanov and J. Ziebuhr
Human Coronavirus 229E Nonstructural Protein 13: Characterization of Duplex-Unwinding, Nucleoside Triphosphatase, and RNA 5'-Triphosphatase Activities
J. Virol., July 15, 2004; 78(14): 7833 - 7838.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. A. Ivanov, V. Thiel, J. C. Dobbe, Y. van der Meer, E. J. Snijder, and J. Ziebuhr
Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase
J. Virol., June 1, 2004; 78(11): 5619 - 5632.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Fayzulin and I. Frolov
Changes of the Secondary Structure of the 5' End of the Sindbis Virus Genome Inhibit Virus Growth in Mosquito Cells and Lead to Accumulation of Adaptive Mutations
J. Virol., May 15, 2004; 78(10): 4953 - 4964.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kim, J. S. L. Parker, K. E. Murray, and M. L. Nibert
Nucleoside and RNA Triphosphatase Activities of Orthoreovirus Transcriptase Cofactor {micro}2
J. Biol. Chem., February 6, 2004; 279(6): 4394 - 4403.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. De, C. Fata-Hartley, S. G. Sawicki, and D. L. Sawicki
Functional Analysis of nsP3 Phosphoprotein Mutants of Sindbis Virus
J. Virol., December 15, 2003; 77(24): 13106 - 13116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Vasiljeva, A. Merits, A. Golubtsov, V. Sizemskaja, L. Kaariainen, and T. Ahola
Regulation of the Sequential Processing of Semliki Forest Virus Replicase Polyprotein
J. Biol. Chem., October 24, 2003; 278(43): 41636 - 41645.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Tuittila and A. E. Hinkkanen
Amino acid mutations in the replicase protein nsP3 of Semliki Forest virus cumulatively affect neurovirulence
J. Gen. Virol., June 1, 2003; 84(6): 1525 - 1533.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Salonen, L. Vasiljeva, A. Merits, J. Magden, E. Jokitalo, and L. Kaariainen
Properly Folded Nonstructural Polyprotein Directs the Semliki Forest Virus Replication Complex to the Endosomal Compartment
J. Virol., February 1, 2003; 77(3): 1691 - 1702.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Heise, L. J. White, D. A. Simpson, C. Leonard, K. A. Bernard, R. B. Meeker, and R. E. Johnston
An Attenuating Mutation in nsP1 of the Sindbis-Group Virus S.A.AR86 Accelerates Nonstructural Protein Processing and Up-Regulates Viral 26S RNA Synthesis
J. Virol., December 20, 2002; 77(2): 1149 - 1156.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. I. Frolova, R. Z. Fayzulin, S. H. Cook, D. E. Griffin, C. M. Rice, and I. Frolov
Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection
J. Virol., October 11, 2002; 76(22): 11254 - 11264.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. C. Vlot, A. Menard, and J. F. Bol
Role of the Alfalfa Mosaic Virus Methyltransferase-Like Domain in Negative-Strand RNA Synthesis
J. Virol., October 11, 2002; 76(22): 11321 - 11328.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. K. Fazakerley, A. Boyd, M. L. Mikkola, and L. Kaariainen
A Single Amino Acid Change in the Nuclear Localization Sequence of the nsP2 Protein Affects the Neurovirulence of Semliki Forest Virus
J. Virol., January 1, 2002; 76(1): 392 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-I. Li, T.-W. Shih, Y.-H. Hsu, Y.-T. Han, Y.-L. Huang, and M. Meng
The Helicase-Like Domain of Plant Potexvirus Replicase Participates in Formation of RNA 5' Cap Structure by Exhibiting RNA 5'-Triphosphatase Activity
J. Virol., December 15, 2001; 75(24): 12114 - 12120.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Kujala, A. Ikäheimonen, N. Ehsani, H. Vihinen, P. Auvinen, and L. Kääriäinen
Biogenesis of the Semliki Forest Virus RNA Replication Complex
J. Virol., April 15, 2001; 75(8): 3873 - 3884.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
A. Merits, L. Vasiljeva, T. Ahola, L. Kääriäinen, and P. Auvinen
Proteolytic processing of Semliki Forest virus-specific non-structural polyprotein by nsP2 protease
J. Gen. Virol., April 1, 2001; 82(4): 765 - 773.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Vihinen and J. Saarinen
Phosphorylation Site Analysis of Semliki Forest Virus Nonstructural Protein 3
J. Biol. Chem., September 1, 2000; 275(36): 27775 - 27783.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Vihinen, T. Ahola, M. Tuittila, A. Merits, and L. Kaariainen
Elimination of Phosphorylation Sites of Semliki Forest Virus Replicase Protein nsP3
J. Biol. Chem., February 16, 2001; 276(8): 5745 - 5752.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Vasiljeva, L. Valmu, L. Kaariainen, and A. Merits
Site-specific Protease Activity of the Carboxyl-terminal Domain of Semliki Forest Virus Replicase Protein nsP2
J. Biol. Chem., August 10, 2001; 276(33): 30786 - 30793.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/23/17281    most recent
M910340199v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasiljeva, L.
Right arrow Articles by Kääriäinen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasiljeva, L.
Right arrow Articles by Kääriäinen, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement